These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31939485)

  • 1. Perspectives on long-acting growth hormone therapy in children and adults.
    Lal RA; Hoffman AR
    Arch Endocrinol Metab; 2019; 63(6):601-607. PubMed ID: 31939485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of long-acting-growth hormone preparations--2015.
    Høybye C; Cohen P; Hoffman AR; Ross R; Biller BM; Christiansen JS;
    Growth Horm IGF Res; 2015 Oct; 25(5):201-6. PubMed ID: 26187188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel long-acting GH preparations.
    Doknic M; Stojanovic M; Popovic V
    Pediatr Endocrinol Rev; 2014 Dec; 12(2):206-12. PubMed ID: 25581986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Acting Growth Hormone Preparations in the Treatment of Children.
    Lal RA; Hoffman AR
    Pediatr Endocrinol Rev; 2018 Sep; 16(Suppl 1):162-167. PubMed ID: 30378794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Weekly Long-Acting Growth Hormone Replacement Therapy Compared to Daily Growth Hormone on Children With Short Stature: A Meta-Analysis.
    Ma L; Li L; Pan W; Huang C; Liu L; Zhang X
    Front Endocrinol (Lausanne); 2021; 12():726172. PubMed ID: 34912293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children.
    Hou L; Chen ZH; Liu D; Cheng YG; Luo XP
    Drug Des Devel Ther; 2016; 10():13-21. PubMed ID: 26719670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Effectiveness and Comparable Safety in Biweekly
    Sun C; Lu B; Liu Y; Zhang Y; Wei H; Hu X; Hu P; Zhao Q; Liu Y; Ye K; Wang K; Gu Z; Liu Z; Ye J; Zhang H; Zhu H; Jiang Z; Liu Y; Wan N; Yan C; Yin J; Ying L; Huang F; Yin Q; Xi L; Luo F; Cheng R
    Front Endocrinol (Lausanne); 2021; 12():779365. PubMed ID: 34899612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing long-acting growth hormone formulations.
    Cawley P; Wilkinson I; Ross RJ
    Clin Endocrinol (Oxf); 2013 Sep; 79(3):305-9. PubMed ID: 23662913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Acting Growth Hormone Preparations - Current Status and Future Considerations.
    Miller BS; Velazquez E; Yuen KCJ
    J Clin Endocrinol Metab; 2020 Jun; 105(6):e2121-33. PubMed ID: 31676901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and in Vivo Characterization of MOD-4023, a Long-Acting Carboxy-Terminal Peptide (CTP)-Modified Human Growth Hormone.
    Hershkovitz O; Bar-Ilan A; Guy R; Felikman Y; Moschcovich L; Hwa V; Rosenfeld RG; Fima E; Hart G
    Mol Pharm; 2016 Feb; 13(2):631-9. PubMed ID: 26713839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of long-acting growth hormone in children with short stature: a systematic review and meta-analysis.
    Yang Y; Bai X; Yuan X; Zhang Y; Chen S; Yang H; Du H; Zhu H; Pan H
    Endocrine; 2019 Jul; 65(1):25-34. PubMed ID: 31119649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current state of long-acting growth hormone preparations for growth hormone therapy.
    Yuen KCJ; Miller BS; Biller BMK
    Curr Opin Endocrinol Diabetes Obes; 2018 Aug; 25(4):267-273. PubMed ID: 29746309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Acting Growth Hormone: An Update.
    Saenger PH; Mejia-Corletto J
    Endocr Dev; 2016; 30():79-97. PubMed ID: 26683877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.
    Kemp SF; Fielder PJ; Attie KM; Blethen SL; Reiter EO; Ford KM; Marian M; Dao LN; Lee HJ; Saenger P
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3234-40. PubMed ID: 15240597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency.
    Moore WV; Nguyen HJ; Kletter GB; Miller BS; Rogers D; Ng D; Moore JA; Humphriss E; Cleland JL; Bright GM
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1091-7. PubMed ID: 26672637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.
    Scalco RC; Melo SS; Pugliese-Pires PN; Funari MF; Nishi MY; Arnhold IJ; Mendonca BB; Jorge AA
    J Clin Endocrinol Metab; 2010 Jan; 95(1):328-32. PubMed ID: 19926713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats.
    Cox GN; Rosendahl MS; Chlipala EA; Smith DJ; Carlson SJ; Doherty DH
    Endocrinology; 2007 Apr; 148(4):1590-7. PubMed ID: 17234711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for growth hormone therapy in children.
    Kirk J
    Arch Dis Child; 2012 Jan; 97(1):63-8. PubMed ID: 21540481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting forms of growth hormone-releasing hormone and growth hormone: effects in normal volunteers and adults with growth hormone deficiency.
    Clemmons DR
    Horm Res; 2007; 68 Suppl 5():178-81. PubMed ID: 18174751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
    Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
    Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.